Neurostimulation Device Market Analysis, Top Companies, New Technology, Demand and Opportunity

As per the Parkinson's Disease Foundation, about 7–10 million people suffer from Parkinson's disease, globally. In the U.S., each year, 60,000 new cases of Parkinson's disease are reported.
Spread the Word
Listed Under

Neurostimulation Device


Avon - Connecticut - US


AVON, Conn. - Jan. 15, 2020 - PRLog -- The World Health Organization said that about 50 million people across the world suffer from epilepsy, and about 2.4 million people are diagnosed with the condition every year. Chronic pain is associated with these diseases and many other conditions and may even be a result of injuries, which greatly affects the way of life. In a study conducted by the International Association for the Study of Pain, it was reported that about 2.8% of the total diabetic population suffered from peripheral neuropathic pain in 2000, and it is predicted to grow to 4.4% by 2030.

Download Sample of This Research Report: (

A neurostimulation device is made of three basic components — a generator, leads, and a programmer. A generator is responsible for sending electrical impulses to the leads; it is implanted in the posterior pelvic region or in the abdominal area. Leads carry electrical impulses from the generator to the nerves of the spinal cord. To block the pain signals, the leads are inserted into the epidural space. The last component is the programmer, which is a handheld device that helps in the adjustments of electrical signals as per the patient's requirement. The whole set up comprises a neurostimulation device, which helps in pain management and studying of the brain activity.

The demand for these devices was the highest in North America among all the regions, namely Asia, Europe, and Rest of the World. This was attributed to the surging geriatric population and the growing incidence of neurological disorders in the region. Further, the popularity of minimally invasive treatment and the increasing research & development activities in the development of innovative neurostimulation devices have been instrumental in driving the regional market forward. The neurostimulation device market ( is expected to register a 12.9% CAGR during 2016–2022.

Chronic pains more commonly affect nerves, bones, and the back. These pains can be debilitating, and to treat them, neurostimulation devices are used. These devices work by generating mild electric signals that reach the brain faster than pain signals, and trick the patient into feeling the tingling sensation instead of pain, they block pain signals before they reach the brain, thereby providing relief to patients. Some common pain management devices available in the neurostimulation device market are peripheral nerve stimulation device and SCS device.

Pramod Kumar
Tags:Neurostimulation Device
Location:Avon - Connecticut - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
P&S Intelligence PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share